Develop and own the multi-year applied omics strategy across reproductive health, agricultural, and human applications, encompassing genomics, epigenomics, transcriptomics, proteomics, and future complementary modalities. Drive innovation by translating customer needs into new genomic, epigenomic, transcriptomic, and proteomic content, applications, workflows, and product capabilities, while identifying opportunities to extend successful solutions across markets.